7-151081596-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001136044.2(TMUB1):āc.694T>Cā(p.Phe232Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000686 in 1,456,736 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001136044.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMUB1 | NM_001136044.2 | c.694T>C | p.Phe232Leu | missense_variant | 3/3 | ENST00000297533.9 | NP_001129516.1 | |
TMUB1 | NM_031434.4 | c.694T>C | p.Phe232Leu | missense_variant | 3/3 | NP_113622.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMUB1 | ENST00000297533.9 | c.694T>C | p.Phe232Leu | missense_variant | 3/3 | 1 | NM_001136044.2 | ENSP00000297533.4 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.0000340 AC: 8AN: 235634Hom.: 0 AF XY: 0.0000464 AC XY: 6AN XY: 129230
GnomAD4 exome AF: 0.00000686 AC: 10AN: 1456736Hom.: 0 Cov.: 32 AF XY: 0.00000966 AC XY: 7AN XY: 724280
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 16, 2021 | The c.694T>C (p.F232L) alteration is located in exon 3 (coding exon 2) of the TMUB1 gene. This alteration results from a T to C substitution at nucleotide position 694, causing the phenylalanine (F) at amino acid position 232 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at